Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $0.97 - $0.97 | $244 |
| 2024-10-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $0.97 - $0.97 | $87 |
| 2024-10-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $0.97 - $0.97 | $2,171 |
| 2024-09-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 1158 | $0.99 - $0.99 | $1,146 |
| 2024-09-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 343 | $0.99 - $0.99 | $339 |
| 2024-09-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 4697 | $0.99 - $0.99 | $4,650 |
| 2024-07-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $0.75 - $0.75 | $189 |
| 2024-07-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $0.75 - $0.75 | $67 |
| 2024-07-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $0.75 - $0.75 | $1,679 |
| 2024-06-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 1158 | $0.80 - $0.80 | $926 |
| 2024-06-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 4697 | $0.80 - $0.80 | $3,757 |
| 2024-06-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 343 | $0.80 - $0.80 | $274 |
| 2024-06-06 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
S | Common Stock | D | 2189 | $0.88 - $0.88 | $1,917 |
| 2024-06-05 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
S | Common Stock | D | 25800 | $0.88 - $0.88 | $22,662 |
| 2024-05-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $0.93 - $0.93 | $234 |
| 2024-05-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $0.93 - $0.93 | $83 |
| 2024-05-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $0.93 - $0.93 | $2,082 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |